Study shows patient on ketogenic diet living fully with IDH1-mutant glioblastoma ANI | Updated: Jun 11, 2021 08:04 IST
Washington [US], June 11 (ANI): A British man who rejected the standard of care to treat his brain cancer has lived with the typically fatal glioblastoma tumour growing very slowly after adopting a ketogenic diet, providing a case study that researchers say reflects the benefits of using the body s own metabolism to fight this particularly aggressive cancer instead of chemo and radiation therapy.
Published in the journal Frontiers in Nutrition, the report is the first evaluation of the use of ketogenic metabolic therapy (KMT) without chemo or radiation interventions, on a patient diagnosed with IDH1-mutantglioblastoma (GBM). Ketogenic therapy is a non-toxic nutritional approach, viewed as complementary or alternative, that uses a low-carbohydrate, high-fat diet to manage a range of cancers, including glioblastoma.